Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.

Female long-term survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) incur a significant burden of late effects. Genital graft-versus-host disease (GVHD), human papillomavirus (HPV) reactivation, ovarian failure and infertility, sexual dysfunction, and osteoporosis are concerns that can significantly impact quality of life. This review examines the risk, pathogenesis, clinical presentation, and implications of these common complications. Recommendations are provided for evaluation and management of these late effects and other obstetric and gynecologic issues that may arise in this patient population.

[1]  Myeong Soo Lee,et al.  Acupuncture for Hot Flushes in Perimenopausal and Postmenopausal Women: A Randomised, Sham-Controlled Trial , 2011, Acupuncture in medicine : journal of the British Medical Acupuncture Society.

[2]  M. Harigopal,et al.  Use of high‐risk human papillomavirus testing in patients with low‐grade squamous intraepithelial lesions , 2011, Cancer cytopathology.

[3]  L. Boni,et al.  Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. , 2011, JAMA.

[4]  E. Anckaert,et al.  Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence. , 2011, Fertility and sterility.

[5]  E. Warnecke.  What works? Evidence for lifestyle and nonprescription therapies in menopause. , 2011, Australian family physician.

[6]  J. Fish.  Part 1: Hormone replacement for survivors of childhood cancer with ovarian failure--when is it worth the risk? , 2011, Journal of pediatric and adolescent gynecology.

[7]  Stephanie J. Lee,et al.  How I treat late effects in adults after allogeneic stem cell transplantation. , 2011, Blood.

[8]  K. P. Jones,et al.  Gynecologic Care in Hematopoietic Stem Cell Transplant Patients: A Review , 2010, Obstetrical & gynecological survey.

[9]  A. Vishnu,et al.  Mind-body therapies for menopausal symptoms: a systematic review. , 2010, Maturitas.

[10]  A. Juul,et al.  Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. , 2010, Fertility and sterility.

[11]  J. Jeruss,et al.  Preservation of fertility in patients with cancer. , 2009, The New England journal of medicine.

[12]  C. Wheeler,et al.  The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. , 2009, The Journal of infectious diseases.

[13]  H. Deeg,et al.  Solid cancers after allogeneic hematopoietic cell transplantation. , 2009, Blood.

[14]  M. Asaka,et al.  HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  M. Hickey,et al.  Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  A. Barrett,et al.  Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  L. Baden,et al.  Vaccination after stem cell transplant: a review of recent developments and implications for current practice , 2008, Current opinion in infectious diseases.

[18]  P. Stratton,et al.  Labial Fusion: A Rare Complication of Chronic Graft-Versus-Host Disease , 2008, Obstetrics and gynecology.

[19]  G. Dini,et al.  Endocrinological late complications after hematopoietic SCT in children , 2008, Bone Marrow Transplantation.

[20]  L. Schover.  Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  B. Kurland,et al.  Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. , 2008, Blood.

[22]  J. Voltarelli,et al.  Ovarian recovery after stem cell transplantation , 2008, Bone Marrow Transplantation.

[23]  A. Nademanee,et al.  Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. , 2007, Blood.

[24]  M. Turner,et al.  Vulvovaginal Chronic Graft-Versus-Host Disease With Allogeneic Hematopoietic Stem Cell Transplantation , 2007, Obstetrics and gynecology.

[25]  S. Rose,et al.  Long-term endocrine sequelae of childhood cancer , 2007, Current opinion in pediatrics.

[26]  Ho-Joon Lee,et al.  Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  F. X. Bosch,et al.  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions , 2007 .

[28]  Daron G Ferris,et al.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. , 2007, The New England journal of medicine.

[29]  C. Nappi,et al.  Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review , 2007, Menopause.

[30]  W. Au,et al.  Challenges and pitfalls in prenatal screening in pregnancies involving allogeneic stem cell transplantation recipients , 2007, Bone Marrow Transplantation.

[31]  J. Szer,et al.  Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management , 2006, Bone Marrow Transplantation.

[32]  D. Green,et al.  Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. , 2006, Journal of the National Cancer Institute.

[33]  L. Robison,et al.  Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the bone marrow transplant survivor study , 2006, Bone Marrow Transplantation.

[34]  V. Pinn,et al.  Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. , 2006, The Journal of reproductive medicine.

[35]  A. Schattenberg,et al.  Quality of life, reproduction and sexuality after stem cell transplantation with partially T-cell-depleted grafts and after conditioning with a regimen including total body irradiation , 2006, Bone Marrow Transplantation.

[36]  L. Gerber,et al.  Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[37]  F. Wojnarowska,et al.  Influence of treatment of erosive lichen planus of the vulva on its prognosis. , 2006, Archives of dermatology.

[38]  G. Christman,et al.  Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. , 2005, Arthritis and rheumatism.

[39]  D. Panidis,et al.  Function of the hypothalamic–pituitary–gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases , 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[40]  F. Orio,et al.  Endocrine disorders during the first year after autologous stem-cell transplant. , 2005, The American journal of medicine.

[41]  W. Travis,et al.  Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. , 2005, Blood.

[42]  Charles Sklar,et al.  Maintenance of ovarian function and risk of premature menopause related to cancer treatment. , 2005, Journal of the National Cancer Institute. Monographs.

[43]  H. Critchley,et al.  Impact of cancer treatment on uterine function. , 2005, Journal of the National Cancer Institute. Monographs.

[44]  R. Soiffer,et al.  Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[45]  J. Berzofsky,et al.  Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. , 2003, The Journal of infectious diseases.

[46]  F. X. Bosch,et al.  Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. , 2003, Journal of the National Cancer Institute. Monographs.

[47]  J. Rock,et al.  Treatment of vaginal agglutination associated with chronic graft-versus-host disease. , 2002, Fertility and sterility.

[48]  R. Kaufman,et al.  Treatment of Vulvovaginal Lichen Planus With Vaginal Hydrocortisone Suppositories , 2002, Obstetrics and gynecology.

[49]  R. Storb,et al.  Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. , 2002, Blood.

[50]  A. Bacigalupo,et al.  Hormone Replacement Therapy and Chronic Graft‐versus‐Host Disease Activity in Women Treated with Bone Marrow Transplantation for Hematologic Malignancies , 2002, Annals of the New York Academy of Sciences.

[51]  E. Norwitz,et al.  Placenta Percreta and Uterine Rupture Associated With Prior Whole Body Radiation Therapy , 2001, Obstetrics and gynecology.

[52]  A. Uutela,et al.  Gender-associated differences in the quality of life after allogeneic BMT , 2001, Bone Marrow Transplantation.

[53]  P. Ljungman,et al.  Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey , 2001, The Lancet.

[54]  A. Nademanee,et al.  Solid cancers after bone marrow transplantation. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  F. Frassoni,et al.  Quality of life in 244 recipients of allogeneic bone marrow transplantation , 2000, British journal of haematology.

[56]  I. Frazer,et al.  HPV6b virus like particles are potent immunogens without adjuvant in man. , 2000, Vaccine.

[57]  A. Tichelli,et al.  Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation , 1999, Annals of Internal Medicine.

[58]  R. Gray,et al.  Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone , 1999, Cancer.

[59]  P. Ljungman,et al.  Norethisterone Treatment, a Major Risk-Factor for Veno-Occlusive Disease in the Liver After Allogeneic Bone Marrow Transplantation , 1998 .

[60]  C. Teinturier,et al.  Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure , 1998, Bone Marrow Transplantation.

[61]  A. Schimmer,et al.  Ovarian function after autologous bone marrow transplantation. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  G. Jackson,et al.  Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UK. , 1997, Leukemia & lymphoma.

[63]  R. Hoover,et al.  Solid cancers after bone marrow transplantation. , 1997, The New England journal of medicine.

[64]  C. Sklar,et al.  Gonadal function after bone marrow transplantation for acute leukemia during childhood. , 1997, The Journal of pediatrics.

[65]  P. Ljungman,et al.  Loss of seroreactivity against human papillomavirus (HPV) in bone marrow transplant recipients. , 1996, Bone Marrow Transplantation.

[66]  J. Lurain,et al.  Unanticipated pregnancy with intrauterine growth retardation after radiation-induced ovarian failure. A case report. , 1996, Journal of reproductive medicine.

[67]  A. Bacigalupo,et al.  Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow up of 79 females. , 1994, Bone marrow transplantation.

[68]  A. Goldstone,et al.  Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in post-menarcheal female patients. , 1994, Bone marrow transplantation.

[69]  D. Linch,et al.  Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol. , 1994, Bone marrow transplantation.

[70]  J. Zucker,et al.  Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. , 1992, The Journal of pediatrics.

[71]  R. Epstein,et al.  Drug-induced DNA damage and tumor chemosensitivity. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[72]  M. Whitehead,et al.  Consequences and treatment of ovarian failure after total body irradiation for leukaemia. , 1989 .

[73]  K. Sullivan,et al.  Ovarian function following marrow transplantation for aplastic anemia or leukemia. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  K. Sullivan,et al.  Gynecologic Manifestations of Chronic Graft-Versus-Host Disease , 1982, Obstetrics and gynecology.

[75]  F. Martin,et al.  Cyclophosphamide-induced ovarian failure. , 1973, The New England journal of medicine.

[76]  M. Marechal,et al.  Severe vaginal chronic graft-versus-host disease (GVHD): two cases with late onset and literature review. , 2010, European journal of gynaecological oncology.

[77]  S. Pavletic,et al.  Chronic Graft versus Host Disease: Interdisciplinary Management: Contents , 2009 .

[78]  V. Stearns.  Serotonergic Agents as an Alternative to Hormonal Therapy for the Treatment of Menopausal Vasomotor Symptoms , 2006, Treatments in endocrinology.

[79]  A. Bacigalupo,et al.  Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. , 2003, Haematologica.